pI: 8.0113 |
Length (AA): 619 |
MW (Da): 70469 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 12
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
136 | 313 | 2b7j (B) | 113 | 290 | 34.00 | 0.0000000015 | 1 | 0.792302 | -1.47 |
138 | 299 | 2ggt (A) | 136 | 297 | 51.00 | 0 | 1 | 0.988023 | -2.09 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127363)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G08950 | copper chaperone SCO1-like protein HCC1 |
Babesia bovis | BBOV_III004250 | SCO1/SenC family protein |
Brugia malayi | Bm1_14745 | transcription initiation factor IIF, alpha subunit, putative |
Candida albicans | CaO19.7325 | inner mitochondrial membrane protein |
Caenorhabditis elegans | CELE_C01F1.2 | Protein SCO-1 |
Dictyostelium discoideum | DDB_G0281505 | hypothetical protein |
Drosophila melanogaster | Dmel_CG8885 | Synthesis of cytochrome c oxidase |
Echinococcus granulosus | EgrG_000228900 | SCO cytochrome oxidase deficient protein 1 |
Echinococcus multilocularis | EmuJ_000228900 | SCO cytochrome oxidase deficient protein 1 |
Homo sapiens | ENSG00000133028 | SCO1 cytochrome c oxidase assembly protein |
Homo sapiens | ENSG00000130489 | SCO2 cytochrome c oxidase assembly protein |
Leishmania braziliensis | LbrM.04.1140 | cytochrome c oxidase assembly factor, putative |
Leishmania braziliensis | LbrM.26.1890 | electon transport protein SCO1/SCO2, putative |
Leishmania donovani | LdBPK_041140.1 | cytochrome c oxidase assembly factor, putative |
Leishmania donovani | LdBPK_261970.1 | electon transport protein SCO1/SCO2, putative |
Leishmania infantum | LinJ.04.1140 | cytochrome c oxidase assembly factor, putative |
Leishmania infantum | LinJ.26.1970 | electon transport protein SCO1/SCO2, putative |
Leishmania major | LmjF.26.1970 | electon transport protein SCO1/SCO2, putative |
Leishmania major | LmjF.04.1130 | cytochrome c oxidase assembly factor, putative |
Leishmania mexicana | LmxM.04.1130 | cytochrome c oxidase assembly factor, putative |
Leishmania mexicana | LmxM.26.1970 | electon transport protein SCO1/SCO2, putative |
Loa Loa (eye worm) | LOAG_07303 | hypothetical protein |
Mus musculus | ENSMUSG00000091780 | SCO cytochrome oxidase deficient homolog 2 (yeast) |
Mus musculus | 52892 | SCO cytochrome oxidase deficient homolog 1 (yeast) |
Neospora caninum | NCLIV_029640 | SCO1/SenC domain-containing protein, putative |
Oryza sativa | 4328372 | Os02g0159700 |
Onchocerca volvulus | OVOC11567 |
|
Plasmodium berghei | PBANKA_1219400 | protein SCO1, putative |
Plasmodium falciparum | PF3D7_0708900 | protein SCO1, putative |
Plasmodium knowlesi | PKNH_0107500 | protein SCO1, putative |
Plasmodium vivax | PVX_087975 | cloroquine resistance associated protein Cg3, putative |
Plasmodium yoelii | PY05062 | Plasmodium falciparum CG3 |
Saccharomyces cerevisiae | YBR024W | Sco2p |
Saccharomyces cerevisiae | YBR037C | Sco1p |
Schistosoma japonicum | Sjp_0094450 | ko:K07152 SCO1, LOC489505; SCO cytochrome oxidase deficient homolog 1 (yeast), putative |
Schistosoma mansoni | Smp_034700.1 | sco1-related |
Schistosoma mansoni | Smp_034700.3 | sco1-related |
Schmidtea mediterranea | mk4.000936.03 | Protein SCO2 homolog, mitochondrial |
Schmidtea mediterranea | mk4.038135.00 | Protein SCO2 homolog, mitochondrial |
Schmidtea mediterranea | mk4.000936.01 | Protein SCO2 homolog, mitochondrial |
Schmidtea mediterranea | mk4.002155.03 | Protein SCO2 homolog, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.9.4780 | cytochrome c oxidase assembly factor, putative |
Trypanosoma brucei gambiense | Tbg972.9.1050 | electon transport protein SCO1/SCO2, putative |
Trypanosoma brucei | Tb927.9.8680 | cytochrome c oxidase assembly factor, putative |
Trypanosoma brucei | Tb427tmp.160.1140 | electon transport protein SCO1/SCO2, putative |
Trypanosoma brucei | Tb927.9.2450 | electon transport protein SCO1/SCO2, putative |
Trypanosoma congolense | TcIL3000_9_650 | electon transport protein SCO1/SCO2, putative |
Trypanosoma cruzi | TcCLB.508351.40 | cytochrome c oxidase assembly factor, putative |
Trypanosoma cruzi | TcCLB.506649.50 | cytochrome c oxidase assembly factor, putative |
Trypanosoma cruzi | TcCLB.509535.9 | electon transport protein SCO1/SCO2, putative |
Trypanosoma cruzi | TcCLB.504423.20 | electon transport protein SCO1/SCO2, putative |
Toxoplasma gondii | TGME49_257440 | SCO1/SenC protein |
Theileria parva | TP02_0242 | SCO1-like, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0544 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.160.1140 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.160.1140 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.160.1140 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.160.1140 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb09.211.0510 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.0510 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.0510 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.211.0510 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C01F1.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C01F1.2 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C01F1.2 | Caenorhabditis elegans | sterile | wormbase |
YBR024W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1219400 | Plasmodium berghei | Essential | plasmo |
TGME49_257440 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Transporter | 617 aa | 37.4% | 586 aa | Compounds | References |
Rattus norvegicus | GABA transporter | 614 aa | 42.6% | 566 aa | Compounds | References |
Rattus norvegicus | GABA transporter 1 | 599 aa | 42.9% | 557 aa | Compounds | References |
Rattus norvegicus | GABA transporter 2 | 602 aa | 41.2% | 592 aa | Compounds | References |
Rattus norvegicus | Norepinephrine transporter | 597 aa | 38.6% | 554 aa | Compounds | References |